From theheart.org on Medscape

Coverage from the

International Stroke Conference (ISC) 2023

February 08 - 10, 2023; Dallas, Texas and Virtual

February 08 - 10, 2023 Dallas, Texas and Virtual

ISC 2023 Tirofiban Superior to Aspirin in Stroke Without Large Occlusion Among patients with disabling strokes without medium or large occlusions, more of those taking tirofiban had good function at 90 days than those on aspirin, results of the RESCUE BT2 trial show.
Medscape Medical News, March 2, 2023
ISC 2023 Drug Combo Promising in Vascular Cognitive Impairment: LACI-2 A combination of two drugs showed promising phase 2 results, including a reduction in cognitive impairment in patients with lacunar stroke, and may be a potential new approach to small vessel disease.
Medscape Medical News, February 13, 2023
ISC 2023 Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2 A new international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice.
Medscape Medical News, February 10, 2023

Conference News

ISC 2023 Tirofiban Superior to Aspirin in Stroke Without Large Occlusion
Medscape Medical News, March 2, 2023
ISC 2023 Endovascular Therapy Benefits Large Infarction: ANGEL-ASPECT
Medscape Medical News, February 16, 2023
ISC 2023 Thrombolysis Not Necessary in Mild Nondisabling Stroke: ARAMIS
Medscape Medical News, February 16, 2023
ISC 2023 Similar Effect of Early, Late BP Reduction in Stroke: CATIS-2
Medscape Medical News, February 15, 2023
ISC 2023 Novel Celery Seed–Derived Drug May Improve Stroke Outcomes
Medscape Medical News, February 15, 2023
ISC 2023 Drug Combo Promising in Vascular Cognitive Impairment: LACI-2
Medscape Medical News, February 13, 2023

ISC 2023 Tenecteplase Noninferior to Alteplase for Ischemic Stroke: TRACE-2
Medscape Medical News, February 13, 2023
ISC 2023 Blood Pressure–Lowering After Thrombectomy May Be Harmful
Medscape Medical News, February 10, 2023
ISC 2023 Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2
Medscape Medical News, February 10, 2023
ISC 2023 Stroke Ready Program Doesn't Increase Thrombolysis Rate
Medscape Medical News, February 10, 2023
ISC 2023 STROKE AF at 3 Years: High AF Rate After Atherosclerotic Stroke
Medscape Medical News, February 9, 2023
ISC 2023 Novel Neuroprotective Agent Promising in Stroke
Medscape Medical News, February 9, 2023

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Top Studies From the 2023 International Stroke Conference
Hans Christoph Diener, MD, PhD

Popular News from ISC 2022

Intra-arterial tPA After Stroke Thrombectomy: 'Remarkable' Benefit Giving intra-arterial thrombolysis after successful thrombectomy for ischemic stroke led to a large increase in excellent neurologic outcomes in CHOICE, a groundbreaking new study.
Medscape Medical News, Feb 11, 2022
Tenecteplase for Stroke Linked to Reduced ICH Risk A new study shows use of tenecteplase is associated with a lower risk of symptomatic intracranial hemorrhage compared with the standard alteplase in patients who have suffered stroke.
Medscape Medical News, Feb 10, 2022
Chronic Marijuana Use Linked to Recurrent Stroke Results of a new observational study suggest the need to raise awareness among young stroke patients about the impact of chronic marijuana use, researchers say.
Medscape Medical News, Feb 08, 2022

Previous Coverage

Related Resource

Stroke/Cerebrovascular Disease